Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-07-31 07:46 am Unchanged |
2024-07-31 | 13G | Xilio Therapeutics, Inc. XLO |
TAKEDA PHARMACEUTICAL CO LTD | 1,475,121 4.000% |
0 (Unchanged) |
Filing History |
2024-04-10 06:10 am Sale |
2024-04-09 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
TAKEDA PHARMACEUTICAL CO LTD | 2,790,480 4.800% |
-362,737![]() (-11.50%) |
Filing History |
2024-04-01 06:15 am Sale |
2024-03-28 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
TAKEDA PHARMACEUTICAL CO LTD | 3,153,217 5.400% |
-602,366![]() (-16.04%) |
Filing History |
2024-02-06 09:36 am Purchase |
2023-12-31 | 13G | Takeda Pharmaceutical Company Limited TAK |
BLACKROCK INC BLK |
121,185,145 7.700% |
7,435,760![]() (+6.54%) |
Filing |
2024-02-05 06:24 am Sale |
2023-12-31 | 13G | Takeda Pharmaceutical Company Limited TAK |
Sumitomo Mitsui Trust Group, Inc. | 87,400,834 5.500% |
-6,198,700![]() (-6.62%) |
Filing History |
2024-01-25 06:11 am Sale |
2024-01-24 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
TAKEDA PHARMACEUTICAL CO LTD | 3,755,583 6.600% |
-3,703,721![]() (-49.65%) |
Filing History |
2024-01-19 06:03 am Purchase |
2023-12-31 | 13G | Equillium, Inc. EQ |
TAKEDA PHARMACEUTICAL CO LTD | 1,842,977 5.200% |
1,842,977![]() (New Position) |
Filing History |
2023-05-26 07:08 am Sale |
2023-04-17 | 13D | Calithera Biosciences, Inc. CALA |
TAKEDA PHARMACEUTICAL CO LTD | 0 0.000% |
-857,844![]() (Position Closed) |
Filing History |
2023-02-07 2:10 pm Purchase |
2022-12-31 | 13G | Takeda Pharmaceutical Company Limited TAK |
BLACKROCK INC BLK |
113,749,385 7.200% |
8,807,433![]() (+8.39%) |
Filing |
2023-02-03 5:06 pm Sale |
2022-06-21 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
TAKEDA PHARMACEUTICAL CO LTD | 0 0.000% |
-6,012,758![]() (Position Closed) |
Filing History |
2023-02-03 11:50 am Unchanged |
2022-06-21 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
TAKEDA PHARMACEUTICAL CO LTD | 0 0.000% |
0 (Unchanged) |
Filing History |
2023-02-03 11:48 am Purchase |
2022-07-01 | 13G | Ovid Therapeutics Inc. OVID |
TAKEDA PHARMACEUTICAL CO LTD | 8,781,996 12.200% |
1,250,000![]() (+16.60%) |
Filing History |
2023-02-03 06:19 am Purchase |
2022-12-31 | 13G | Takeda Pharmaceutical Company Limited TAK |
Sumitomo Mitsui Trust Group, Inc. | 93,599,534 5.900% |
2,685,800![]() (+2.95%) |
Filing History |
2022-08-04 7:59 pm Unchanged |
2022-03-25 | 13G | BiomX Inc. PHGE |
TAKEDA PHARMACEUTICAL CO LTD | 147,829 4.960% |
0 (Unchanged) |
Filing History |
2022-07-06 06:12 am Purchase |
2022-07-01 | 13D | Calithera Biosciences, Inc. CALA |
TAKEDA PHARMACEUTICAL CO LTD | 857,844 15.000% |
116,970![]() (+15.79%) |
Filing History |
2022-05-09 06:08 am Purchase |
2022-04-28 | 13D | HilleVax, Inc. HLVX |
TAKEDA PHARMACEUTICAL CO LTD | 6,724,000 17.100% |
6,724,000![]() (New Position) |
Filing History |
2022-04-21 06:06 am Purchase |
2021-10-18 | 13D | Calithera Biosciences, Inc. CALA |
TAKEDA PHARMACEUTICAL CO LTD | 740,874 13.200% |
740,874![]() (New Position) |
Filing History |
2022-02-04 06:09 am Sale |
2021-12-31 | 13G | Takeda Pharmaceutical Company Limited TAK |
Sumitomo Mitsui Trust Group, Inc. | 90,913,734 5.700% |
-3,120,300![]() (-3.32%) |
Filing History |
2022-02-02 7:18 pm Purchase |
2021-12-31 | 13G | Takeda Pharmaceutical Company Limited TAK |
BLACKROCK INC BLK |
104,941,952 6.600% |
5,393,016![]() (+5.42%) |
Filing |
2022-01-14 06:07 am Purchase |
2021-12-31 | 13G | Xilio Therapeutics, Inc. XLO |
TAKEDA PHARMACEUTICAL CO LTD | 1,475,121 5.370% |
1,475,121![]() (New Position) |
Filing History |